DEXCOM INC — Director's Dealing 2025

May 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2025-05-22

Reporting Person: Coleman Jon (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-22	Common Stock	A	68738	—	Acquired	68738	Direct

Footnotes

F1: Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in four equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.